Patient-Reported Outcomes (Pros) Of Cemiplimab Vs Chemotherapy In Advanced Non-Small Cell Lung Cancer (Ansclc): EMPOWER-Lung 1 Histology Subgroups

Thumbnail
Göster/Aç
Tarih
2022
Yazar
Sezer, A.
Kilickap, S.
Gumus, M.
Bondarenko, I.
Ozguroglu, M.
Gogishvili, M.
He, X.
Gullo, G.
Rietschel, P.
Quek, R.
Üst veri
Tüm öğe kaydını göster
Bağlantı
https://reader.elsevier.com/reader/sd/pii/S092375342203157X?token=CE440C703142DFD2F8552550E5FFE69B6C4BADA16CE67888407EC9305C61FAC843557A9FCF93829AF385621391C51EF6&originRegion=eu-west-1&originCreation=20230102074310
http://hdl.handle.net/11727/8489
Koleksiyonlar